Health Archive » March, 2007

Health - March, 2007

146 articles

• California Pharmas Spar Over Chinese Licensing
• E.U. Targets Boehringer For Misuse Of Patent System
• New Legislation Protects Nurse Whistleblowers
• Federal Circuit Backs Teva In Patent Challenge
• Plaintiff Can't Cherry-Pick Court, Judges Rule
• Abott Sues Teva, Sandoz, Ranbaxy Over Omnicef
• Novartis Stops Drug Marketing Amid Safety Concerns
• Scrushy Violated Terms Of Release: Government
• Outstanding Women: Anthea Daniels
• Biolase Buries Hatchet In Securities Class Action
• Pa. Health Insurers' Merger Stirs Antitrust Concerns
• Eckerd Prevails In Appeal Of FLSA Case
• Merck Wins Appeal To Prohibit Generic Eye Drug
• Merck's Fosamax Patent Reinstated In E.U.
• Stryker Unit Wins Summary Judgment In Patent Case
• Schering Takes Aim At Glenmark Over Zetia
• DVI Exec Sentenced For Financing Fraud
• Jury Makes Diomed $12.5M Richer
• FDA Moves To Improve In Wake Of Safety Scrutiny
• Settlements With Payments To Generics Increase: FTC
• Tyco Files Suit Over Generic Sleep Aid
• Unions Sue New York Over Hospital Overhaul Plans
• Firm Faces Trial Over Fen-Phen Settlement
• Pittsburgh Hospital Deal Comes Under Scrutiny
• Hemosol Granted Fourth Stay Extension
• Illinois Jury Hands Merck A Win
• Critics Say Biologics Bill Doesn't Protect Innovators
• Merck KGaA Unit Files Patent Suit Against Sepracor
• Supreme Court Thwarts Whistleblower's Payday
• FDA Banned From Approving More Generic Norvasc
• Bayer, Novartis Settle MS Drug Dispute For $200M
• Italy Orders Merck To Grant Free Licenses
• NYC Withdraws $3.75M Claim Against Curative
• Biovail Fires Kasowitz Benson In Document Debacle
• Court Reverses NLRB "Supervisor" Ruling
• Pfizer Fills Shelves With Generic Norvasc
• Witnesses Voice Support For Biologic Pathway
• BioSafe Creditors Bid For Chapter 11 Trustee
• Judge Grants St. Vincent Time To Win Favor
• Eisai Targeted Again Over Aciphex Patent
• Federal Circuit Affirms Syringe Patents' Invalidity
• FTC Taps Cephalon Again Over Provigil Deal
• Mylan Races To Launch Generic Norvasc
• Medical Malpractice Payouts Rising: DOJ Study
• Pharmaceutical Holdings Admits Infringement In Deal
• Amgen Asks High Court To Hear Landmark Case
• Permanent Injunction Ends Topamax Patent Fight
• Holland Snags Former Illinois AG Senior Counsel
• Court Dismisses Patent Suit Against Stryker
• Appeals Court Deals Blow To Pfizer
• Shire Ensnares Another Generic Co. Over Adderall
• Blue Cross Draws $1M Fine For Cancellation Policies
• Pfizer Whistleblower Challenges Claim Dismissal
• IRS Issues Complex Guidance On Rollovers To HSAs
• Oxfam Slams Abbott Over Thailand Standoff
• Barr Sued Over Plan For Schizophrenia Drug
• FDA Proposes Tougher Guidelines For Advisers
• Takeda Wins $16.8M In Fees For Misconduct
• Medtronic Wins Appeal Over Spinal Technology
• Interest Group Has No Standing In Medicare Suit
• Cardinal Health Sued Over Tissue Implant Patents
• Pfizer Wins Celebrex Challenge
• AMA Asks DOJ To Block UnitedHealth Merger
• High Court Seeks U.S. Opinion On Tamoxifen Case
• Alexion's Soliris Blood Drug Draws New Patent Cases
• Court Upholds FDA Ban On Diet Pills
• Medtronic Sues Cordis In New Stent Dispute
• Milberg Weiss Class Action Bid Denied
• Ex-Scrushy Bodyguard Wins $1.9M
• Hospital Settles Medicare Allegations For $7.5M
• D.C. Court Rebuffs Challenge To Pharmaceutical Statute
• Lawmakers To Probe Fresh Walter Reed Charges
• Appeals Court Overturns Contraception Ruling
• DNA Manufacturer Sued For Patent Infringement
• Ex-Morgan Crucible CEO To Appeal Extradition
• Lawmakers Urge Panel To Preserve Hospital Funding
• Angiotech Triumphs In Stent Patent Appeal
• Pepper Hamilton Snatches Attorney From DOJ
• Court Shakes Head At UnitedHealth Bid
• Judge Orders Amerigroup To Cough Up $334M
• Zonare Lobs Counterclaims In Ultrasound Patent Spat
• Blue Cross Sued Over Residential Coverage Limits
• Wyeth Sues Fourth Drug Maker Over Generic Effexor
• Glaxo Receives France's First Predatory Pricing Fine
• J&J Subpoenaed Over Topamax, Risperdal, Natrecor
• Cigna Sued Over Treatment For Eating Disorders
• Dana Agrees To $78M Trust For Nonunion Retirees
• Braintree Labs Hit With Antitrust Suit Over MiraLax
• Abbott Strikes Back In Thailand Drug Feud
• Judge Tosses Counterclaims In Eye Surgery Spat
• Illumina Infringed Gene Detection Patents: Jury
• HIPAA Violation May Form Basis for Lawsuit
• Court To Rethink Enzo Patent Bid
• Guilty Plea Entered In Walter Reed Kickback Scheme
• Pepper Hamilton Strengthens IP Group
• Plaintiffs Appeal Dismissal Of United American Suit
• FDA Probes Off-Label Uses Of Drug-Coated Stents
• FTC Follows Through On Express Scripts Query
• Jury Rules Vioxx Caused Heart Attack, Awards $47.5M
• Davis Wright Adds Two More Health Lawyers
• FDA Issues New Anemia Drug Warnings
• Top Biotech IP Attorney Joins Holland & Knight
• Jury To Decide Validity Of Iridex Patent
• Our Lady Of Mercy Files For Chapter 11
• Express Scripts Maintains Antitrust OK Within Reach
• Federal Circuit Delivers Blow To Abbott
• Judge Endorses Saint Vincent Commitment Letter
• Generic Pathway For Biologics Weighed At Hearing
• UnitedHealth To Correct Its Options Grant Dates
• California Doctors Claim Blue Cross Payments Unfair
• Suit Comes Back To Haunt Medtronic
• DOJ, SEC Reach Deal In Drug Maker's Insider-Trading
• St. Vincent, Consultant Fight Over Fees
• Antitrust Suit: Purdue Pharma Tricked PTO
• D.C. Court Reinstates PBM Disclosure Laws
• Judge Allows $8.7M Ruling In Vioxx Case To Stand
• Express Scripts' Sweetened Bid Turns Sour
• Effect Of Deficit Reduction Act On Medicaid Providers
• Judge Lifts Injunction On Drug Maker
• Genentech, Tercica, Insmed Settle Patent Suit
• Spine Implant Suit Disappears After A Day
• EEOC Smacks Walgreens With Race Bias Suit
• Possis Medical Shareholders Appeal Dismissal
• Lawmakers Vow To Mend Veteran Care System
• Solvay Loses False Advertising, Trademark Case
• House Committee Probes Drug Makers
• Judge Declines To Overturn Vioxx Jury Verdict
• Washington Sues Over Infant Coverage Laws
• Novartis Refuses To Yank Gleevec Lawsuit
• Gore-Tex Maker Sued Over Surgical Material
• Sandoz Sued Over Schizophrenia Drug Patent
• QLT, Novartis Settle Patent Dispute With Hospitals
• AG Probes Hospital Security Breach
• Roche Suit Over Diabetes Test Strips Crumbles
• Biovail Abandons Wellbutrin Litigation
• The EEOC's New Treatment Of Health Care Workers
• Elan Targeted In Off-Label Marketing Probe
• Oxford Health Fails To Thwart Doctors' Class Action
• Report Proposes Big Cuts In Managed Medicare
• New Jersey Jury Splits In Vioxx Cases
• U.K. Court Greenlights Pfizer Drug Supply Deal
• Russia Launches Probe Of Glaxo Vaccine Trials
• FirstHealth's Trademark Challenge Founders
• Software Maker Sues Boston Scientific For Piracy
• Express Scripts Seeks New Vote Delay
• Third Wave Files Antitrust Claim Over HPV Test